Article

Hepatoblastoma exhibits a predominantly myeloid immune landscape and reveals opportunities for macrophage targeted immunotherapy

2023-06-28

Abstract excerpt

<h4>Background & Aims</h4> Hepatoblastoma (HB) is a rare form of pediatric liver cancer which is currently treated with chemotherapy and surgery. The side effects of chemotherapy pose a major problem in HB and underline the need for an alternative treatment option. We aimed to characterize the immune landscape of HB to improve our understanding of the immunologic contribution to this disease and explore immunothe...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 56627aa6-e39b-5aa8-ad55-8b7b02f1e334
DOI: 10.1101/2023.06.28.546852

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Hepatoblastoma exhibits a predominantly myeloid immune landscape and reveals opportunities for macrophage targeted immunotherapyDOI 10.1101/2023.06.28.546852Read

The Oncology of Liver Cancer: Integrating Molecular Insights with Therapeutic InnovationSemantic proximity Read

Hepatocellular Carcinoma Immune Landscape and the Potential of Immunotherapies.Semantic proximity Read

Global immune characterization of HBV/HCV-related hepatocellular carcinoma identifies macrophage and T-cell subsets associated with disease progressionSemantic proximity Read

Myeloid cell path to malignancy: insights into liver cancerSemantic proximity Read

TREM1 <sup>+</sup> regulatory myeloid cells expand in steatohepatitis-HCC and associate with poor prognosis and therapeutic resistance to immune checkpoint blockadeSemantic proximity Read

Integrated Multi-Omics Landscape of Liver Metastases.Semantic proximity Read

Single-cell characterization of macrophages in glioblastoma reveals MARCO as a mesenchymal pro-tumor marker.Semantic proximity Read

High ratio of resident to exhausted CD4+ T cells predicts favorable prognosis and potentially better immunotherapeutic efficacy in hepatocellular carcinomaSemantic proximity Read

The Immune–Genomics of Cholangiocarcinoma: A Biological Footprint to Develop Novel ImmunotherapiesSemantic proximity Read

Multi-Omics Deciphering of the Characteristics, Functional Mechanisms, and Prognostic Value of Tumor-Associated Macrophage Subsets in Hepatocellular CarcinomaSemantic proximity Read

Programs, Origins, and Niches of Immunomodulatory Myeloid Cells in GliomasSemantic proximity Read